img

Global Recombinant DNA Technology Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Recombinant DNA Technology Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Recombinant DNA Technology Market
Global Recombinant DNA Technology market is expected to reach to US$ 3284.7 million in 2023, with a positive growth of %, compared with US$ 3023.5 million in 2022. Backed with the increasing demand from downstream industries, Recombinant DNA Technology industry is evaluated to reach US$ 5388.6 million in 2033. The CAGR will be 8.6% during 2023 to 2033.
Globally, Recombinant DNA Technology key companies include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. Monsanto Company, Roche, Biogen are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Recombinant DNA Technology were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Recombinant DNA Technology market and estimated to attract more attentions from industry insiders and investors.
Recombinant DNA Technology can be divided into Therapeutic Agent, Vaccine, Biotech Crops and Specialty Chemicals, etc. Therapeutic Agent is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Recombinant DNA Technology is widely used in various fields, such as Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes and Others,, etc. Biotechnology and Pharmaceutical Companies provides greatest supports to the Recombinant DNA Technology industry development. In 2022, global % revenue of Recombinant DNA Technology went into Biotechnology and Pharmaceutical Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Recombinant DNA Technology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Recombinant DNA Technology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Segment by Type
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals

Segment by Application


Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Recombinant DNA Technology introduction, etc. Recombinant DNA Technology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Recombinant DNA Technology
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Therapeutic Agent
1.2.3 Vaccine
1.2.4 Biotech Crops
1.2.5 Specialty Chemicals
1.3 Market by Application
1.3.1 Global Recombinant DNA Technology Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA Technology Market Perspective (2018-2033)
2.2 Global Recombinant DNA Technology Growth Trends by Region
2.2.1 Recombinant DNA Technology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Recombinant DNA Technology Historic Market Size by Region (2018-2023)
2.2.3 Recombinant DNA Technology Forecasted Market Size by Region (2024-2033)
2.3 Recombinant DNA Technology Market Dynamics
2.3.1 Recombinant DNA Technology Industry Trends
2.3.2 Recombinant DNA Technology Market Drivers
2.3.3 Recombinant DNA Technology Market Challenges
2.3.4 Recombinant DNA Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Recombinant DNA Technology by Players
3.1.1 Global Recombinant DNA Technology Revenue by Players (2018-2023)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Recombinant DNA Technology, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Recombinant DNA Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2022
3.5 Global Key Players of Recombinant DNA Technology Head office and Area Served
3.6 Global Key Players of Recombinant DNA Technology, Product and Application
3.7 Global Key Players of Recombinant DNA Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA Technology Breakdown Data by Type
4.1 Global Recombinant DNA Technology Historic Market Size by Type (2018-2023)
4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2033)
5 Recombinant DNA Technology Breakdown Data by Application
5.1 Global Recombinant DNA Technology Historic Market Size by Application (2018-2023)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Recombinant DNA Technology Market Size (2018-2033)
6.2 North America Recombinant DNA Technology Market Size by Type
6.2.1 North America Recombinant DNA Technology Market Size by Type (2018-2023)
6.2.2 North America Recombinant DNA Technology Market Size by Type (2024-2033)
6.2.3 North America Recombinant DNA Technology Market Share by Type (2018-2033)
6.3 North America Recombinant DNA Technology Market Size by Application
6.3.1 North America Recombinant DNA Technology Market Size by Application (2018-2023)
6.3.2 North America Recombinant DNA Technology Market Size by Application (2024-2033)
6.3.3 North America Recombinant DNA Technology Market Share by Application (2018-2033)
6.4 North America Recombinant DNA Technology Market Size by Country
6.4.1 North America Recombinant DNA Technology Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Recombinant DNA Technology Market Size by Country (2018-2023)
6.4.3 North America Recombinant DNA Technology Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Recombinant DNA Technology Market Size (2018-2033)
7.2 Europe Recombinant DNA Technology Market Size by Type
7.2.1 Europe Recombinant DNA Technology Market Size by Type (2018-2023)
7.2.2 Europe Recombinant DNA Technology Market Size by Type (2024-2033)
7.2.3 Europe Recombinant DNA Technology Market Share by Type (2018-2033)
7.3 Europe Recombinant DNA Technology Market Size by Application
7.3.1 Europe Recombinant DNA Technology Market Size by Application (2018-2023)
7.3.2 Europe Recombinant DNA Technology Market Size by Application (2024-2033)
7.3.3 Europe Recombinant DNA Technology Market Share by Application (2018-2033)
7.4 Europe Recombinant DNA Technology Market Size by Country
7.4.1 Europe Recombinant DNA Technology Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Recombinant DNA Technology Market Size by Country (2018-2023)
7.4.3 Europe Recombinant DNA Technology Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Recombinant DNA Technology Market Size (2018-2033)
8.2 China Recombinant DNA Technology Market Size by Type
8.2.1 China Recombinant DNA Technology Market Size by Type (2018-2023)
8.2.2 China Recombinant DNA Technology Market Size by Type (2024-2033)
8.2.3 China Recombinant DNA Technology Market Share by Type (2018-2033)
8.3 China Recombinant DNA Technology Market Size by Application
8.3.1 China Recombinant DNA Technology Market Size by Application (2018-2023)
8.3.2 China Recombinant DNA Technology Market Size by Application (2024-2033)
8.3.3 China Recombinant DNA Technology Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Recombinant DNA Technology Market Size (2018-2033)
9.2 Asia Recombinant DNA Technology Market Size by Type
9.2.1 Asia Recombinant DNA Technology Market Size by Type (2018-2023)
9.2.2 Asia Recombinant DNA Technology Market Size by Type (2024-2033)
9.2.3 Asia Recombinant DNA Technology Market Share by Type (2018-2033)
9.3 Asia Recombinant DNA Technology Market Size by Application
9.3.1 Asia Recombinant DNA Technology Market Size by Application (2018-2023)
9.3.2 Asia Recombinant DNA Technology Market Size by Application (2024-2033)
9.3.3 Asia Recombinant DNA Technology Market Share by Application (2018-2033)
9.4 Asia Recombinant DNA Technology Market Size by Region
9.4.1 Asia Recombinant DNA Technology Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Recombinant DNA Technology Market Size by Region (2018-2023)
9.4.3 Asia Recombinant DNA Technology Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Type
10.2.1 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Recombinant DNA Technology Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Application
10.3.1 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Recombinant DNA Technology Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Country
10.4.1 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Monsanto Company
11.1.1 Monsanto Company Company Details
11.1.2 Monsanto Company Business Overview
11.1.3 Monsanto Company Recombinant DNA Technology Introduction
11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2018-2023)
11.1.5 Monsanto Company Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Recombinant DNA Technology Introduction
11.2.4 Roche Revenue in Recombinant DNA Technology Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Recombinant DNA Technology Introduction
11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2018-2023)
11.3.5 Biogen Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Recombinant DNA Technology Introduction
11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2018-2023)
11.4.5 Amgen Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Recombinant DNA Technology Introduction
11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2018-2023)
11.5.5 Novartis Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2018-2023)
11.6.5 Eli Lilly and Company Recent Developments
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant DNA Technology Introduction
11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2018-2023)
11.7.5 GenScript Recent Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2018-2023)
11.8.5 Pfizer Inc. Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Recombinant DNA Technology Introduction
11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2018-2023)
11.9.5 Novo Nordisk Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Recombinant DNA Technology Introduction
11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2018-2023)
11.10.5 Sanofi Recent Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Recombinant DNA Technology Introduction
11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2018-2023)
11.11.5 Merck KGaA Recent Developments
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen Recombinant DNA Technology Introduction
11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2018-2023)
11.12.5 Profacgen Recent Developments
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Recombinant DNA Technology Introduction
11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2018-2023)
11.13.5 Biocon Recent Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2018-2023)
11.14.5 GlaxoSmithKline Recent Developments
11.15 Cibus
11.15.1 Cibus Company Details
11.15.2 Cibus Business Overview
11.15.3 Cibus Recombinant DNA Technology Introduction
11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2018-2023)
11.15.5 Cibus Recent Developments
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Details
11.16.2 Horizon Discovery Group Business Overview
11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2018-2023)
11.16.5 Horizon Discovery Group Recent Developments
11.17 New England Biolabs
11.17.1 New England Biolabs Company Details
11.17.2 New England Biolabs Business Overview
11.17.3 New England Biolabs Recombinant DNA Technology Introduction
11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2018-2023)
11.17.5 New England Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Therapeutic Agent
Table 3. Key Players of Vaccine
Table 4. Key Players of Biotech Crops
Table 5. Key Players of Specialty Chemicals
Table 6. Global Recombinant DNA Technology Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Recombinant DNA Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Recombinant DNA Technology Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Recombinant DNA Technology Market Share by Region (2018-2023)
Table 10. Global Recombinant DNA Technology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Recombinant DNA Technology Market Share by Region (2024-2033)
Table 12. Recombinant DNA Technology Market Trends
Table 13. Recombinant DNA Technology Market Drivers
Table 14. Recombinant DNA Technology Market Challenges
Table 15. Recombinant DNA Technology Market Restraints
Table 16. Global Recombinant DNA Technology Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Recombinant DNA Technology Revenue Share by Players (2018-2023)
Table 18. Global Top Recombinant DNA Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
Table 19. Global Recombinant DNA Technology Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Recombinant DNA Technology, Headquarters and Area Served
Table 22. Global Key Players of Recombinant DNA Technology, Product and Application
Table 23. Global Key Players of Recombinant DNA Technology, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2018-2023)
Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2024-2033)
Table 29. Global Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Recombinant DNA Technology Revenue Share by Application (2018-2023)
Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Recombinant DNA Technology Revenue Share by Application (2024-2033)
Table 33. North America Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Recombinant DNA Technology Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Recombinant DNA Technology Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Recombinant DNA Technology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Recombinant DNA Technology Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Recombinant DNA Technology Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Recombinant DNA Technology Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Recombinant DNA Technology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Recombinant DNA Technology Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Recombinant DNA Technology Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Recombinant DNA Technology Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Recombinant DNA Technology Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Recombinant DNA Technology Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Recombinant DNA Technology Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Recombinant DNA Technology Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Recombinant DNA Technology Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Recombinant DNA Technology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size by Country (2024-2033) & (US$ Million)
Table 65. Monsanto Company Company Details
Table 66. Monsanto Company Business Overview
Table 67. Monsanto Company Recombinant DNA Technology Product
Table 68. Monsanto Company Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 69. Monsanto Company Recent Developments
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Recombinant DNA Technology Product
Table 73. Roche Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 74. Roche Recent Developments
Table 75. Biogen Company Details
Table 76. Biogen Business Overview
Table 77. Biogen Recombinant DNA Technology Product
Table 78. Biogen Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 79. Biogen Recent Developments
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Recombinant DNA Technology Product
Table 83. Amgen Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 84. Amgen Recent Developments
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Recombinant DNA Technology Product
Table 88. Novartis Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 89. Novartis Recent Developments
Table 90. Eli Lilly and Company Company Details
Table 91. Eli Lilly and Company Business Overview
Table 92. Eli Lilly and Company Recombinant DNA Technology Product
Table 93. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 94. Eli Lilly and Company Recent Developments
Table 95. GenScript Company Details
Table 96. GenScript Business Overview
Table 97. GenScript Recombinant DNA Technology Product
Table 98. GenScript Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 99. GenScript Recent Developments
Table 100. Pfizer Inc. Company Details
Table 101. Pfizer Inc. Business Overview
Table 102. Pfizer Inc. Recombinant DNA Technology Product
Table 103. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 104. Pfizer Inc. Recent Developments
Table 105. Novo Nordisk Company Details
Table 106. Novo Nordisk Business Overview
Table 107. Novo Nordisk Recombinant DNA Technology Product
Table 108. Novo Nordisk Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 109. Novo Nordisk Recent Developments
Table 110. Sanofi Company Details
Table 111. Sanofi Business Overview
Table 112. Sanofi Recombinant DNA Technology Product
Table 113. Sanofi Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 114. Sanofi Recent Developments
Table 115. Merck KGaA Company Details
Table 116. Merck KGaA Business Overview
Table 117. Merck KGaA Recombinant DNA Technology Product
Table 118. Merck KGaA Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 119. Merck KGaA Recent Developments
Table 120. Profacgen Company Details
Table 121. Profacgen Business Overview
Table 122. Profacgen Recombinant DNA Technology Product
Table 123. Profacgen Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 124. Profacgen Recent Developments
Table 125. Biocon Company Details
Table 126. Biocon Business Overview
Table 127. Biocon Recombinant DNA Technology Product
Table 128. Biocon Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 129. Biocon Recent Developments
Table 130. GlaxoSmithKline Company Details
Table 131. GlaxoSmithKline Business Overview
Table 132. GlaxoSmithKline Recombinant DNA Technology Product
Table 133. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 134. GlaxoSmithKline Recent Developments
Table 135. Cibus Company Details
Table 136. Cibus Business Overview
Table 137. Cibus Recombinant DNA Technology Product
Table 138. Cibus Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 139. Cibus Recent Developments
Table 140. Horizon Discovery Group Company Details
Table 141. Horizon Discovery Group Business Overview
Table 142. Horizon Discovery Group Recombinant DNA Technology Product
Table 143. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 144. Horizon Discovery Group Recent Developments
Table 145. New England Biolabs Company Details
Table 146. New England Biolabs Business Overview
Table 147. New England Biolabs Recombinant DNA Technology Product
Table 148. New England Biolabs Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 149. New England Biolabs Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA Technology Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Recombinant DNA Technology Market Share by Type: 2022 VS 2033
Figure 3. Therapeutic Agent Features
Figure 4. Vaccine Features
Figure 5. Biotech Crops Features
Figure 6. Specialty Chemicals Features
Figure 7. Global Recombinant DNA Technology Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Recombinant DNA Technology Market Share by Application: 2022 VS 2033
Figure 9. Biotechnology and Pharmaceutical Companies Case Studies
Figure 10. Academic & Government Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Recombinant DNA Technology Report Years Considered
Figure 13. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Recombinant DNA Technology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Recombinant DNA Technology Market Share by Region: 2022 VS 2033
Figure 16. Global Recombinant DNA Technology Market Share by Players in 2022
Figure 17. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2022
Figure 19. North America Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Recombinant DNA Technology Market Share by Type (2018-2033)
Figure 21. North America Recombinant DNA Technology Market Share by Application (2018-2033)
Figure 22. North America Recombinant DNA Technology Market Share by Country (2018-2033)
Figure 23. United States Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Recombinant DNA Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Recombinant DNA Technology Market Share by Type (2018-2033)
Figure 27. Europe Recombinant DNA Technology Market Share by Application (2018-2033)
Figure 28. Europe Recombinant DNA Technology Market Share by Country (2018-2033)
Figure 29. Germany Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Recombinant DNA Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Recombinant DNA Technology Market Share by Type (2018-2033)
Figure 37. China Recombinant DNA Technology Market Share by Application (2018-2033)
Figure 38. Asia Recombinant DNA Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Recombinant DNA Technology Market Share by Type (2018-2033)
Figure 40. Asia Recombinant DNA Technology Market Share by Application (2018-2033)
Figure 41. Asia Recombinant DNA Technology Market Share by Region (2018-2033)
Figure 42. Japan Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Recombinant DNA Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Recombinant DNA Technology Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Recombinant DNA Technology Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Recombinant DNA Technology Market Share by Country (2018-2033)
Figure 52. Brazil Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Recombinant DNA Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 60. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 61. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 64. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 65. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 66. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 67. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 68. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 69. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 70. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 71. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 72. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 73. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 74. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries